Vascular endothelial growth factor and interleukin-8 are associated with poor prognosis in epithelial ovarian cancer patients

Clinical Biochemistry

Volumn 37, Issue 5, 2004, Pages 363-369

  Kassim, Samar K ^a   El Salahy, Eman M ^a   Fayed, Salah T ^a   Helal, Sahar A ^a   Helal, Thanaa ^a   Azzam, Ezz El Din ^a   Khalifa, Ali ^a  

^a AIN SHAMS UNIVERSITY   (Egypt)

Author keywords

IL 8; Ovarian cancer; VEGF

Indexed keywords

INTERLEUKIN 8; VASCULOTROPIN;

ADULT; AGED; ARTICLE; BENIGN TUMOR; CANCER STAGING; CONTROLLED STUDY; CORRELATION ANALYSIS; CYTOSOLIC FRACTION; ENZYME IMMUNOASSAY; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; OVARY CANCER; PRIORITY JOURNAL; PROGNOSIS; PROTEIN ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STATISTICAL ANALYSIS; TISSUE SECTION; WESTERN BLOTTING;

BLOTTING, WESTERN; FEMALE; HUMANS; IMMUNOENZYME TECHNIQUES; IMMUNOHISTOCHEMISTRY; INTERLEUKIN-8; NEOPLASM STAGING; NEOPLASMS, GLANDULAR AND EPITHELIAL; OVARIAN NEOPLASMS; PROGNOSIS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SURVIVAL ANALYSIS; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 1842850792     PISSN: 00099120     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.clinbiochem.2004.01.014     Document Type: Article

References (32)

1. Wingo P.A., Tong T., Bolden S. Cancer statistics 1995. Cancer J. Clin. 45:1995;8-30.
2. Fidler I.F., Ellis L.M. The implications of angiogenesis for the biology and therapy of cancer metastasis. Cell. 79:1994;185-188.
3. Fujimoto J., Hosoda S., Fujita H., Okada H. Inhibition of tumor angiogenesis activity by medroxyprogesterone acetate in gynecologic malignant tumors. Invasion Metastasis. 9:1989;269-277.
4. Connolly D.T., Heuvelman D.M., Nelsen R.et al. Tumor vascular permeability factor stimulates endothelial cell growth and angiogenesis. J. Clin. Invest. 84:1989;1470-1478.
5. Senger D., Van De Water L., Brown L.et al. Vascular permeability factor (VPF, VEGF) in tumor biology. Cancer Metastasis Rev. 12:1993;303-324.
6. Fujimoto J., Sakaguchi H., Hirose R., Ichigo S., Tamaya T. Biologic implications of the expression of the vascular endothelial growth factor subtypes in ovarian carcinoma. Cancer. 83:1998;2528-2533.
7. Malik S., Balkwill F. Epithelial ovarian cancer: a cytokine propelled disease? Br. J. Cancer. 64:1991;617-620.
8. Koch A.E., Polverini P.J., Kunkel S.L.et al. Interleukin-8 as a macrophage-derived mediator of angiogenesis. Science. 258:1992;1798-1801.
9. Brew R., Southern S.A., Flanagan B.F., McDicken I.W., Christmas S.E. Detection of interleukin-8 mRNA and protein in human colorectal carcinoma cells. Eur. J. Cancer. 32A:1996;2142-2147.
10. Green A.R., Green V.L., White M.C., Speirs V. Expression of cytokine messenger RNA in normal and neoplastic human breast tissue: identification of interleukin-8 as a potential regulatory factor in breast tumors. Int. J. Cancer. 72:1997;937-941.
11. Ferrer F.A., Miller L.J., Andrawis R.I., Kurtzman S.H., Albertsen P.C., Laudone V.P.et al. Angiogenesis and prostate cancer: in vivo and in vitro expression of angiogenesis factors by prostate cancer cells. Urology. 51:1998;161-166.
12. FIGO staging as published in Am J Obstet Gynecol 156 (1987) 263.
13. Mabrouk G.M., Helal S.A., El-Lamie K.I., Khalifa A. Quantitative measurement of c-erb B-2 p185 and mutant p53 expression in ovarian neoplasms by EIA. Clin. Chem. 42:1996;981-985.
14. Bradford M.M. A rapid and sensitive method for quantification of microgram quantities of protein utilizing the principle of protein dye binding. Anal. Biochem. 62:1976;248-251.
15. Sambrook J., Fritsch E.F., Maniatis T. Third ed. Molecular Cloning. vol. 18:1989;42-59 Cold Spring Harbor Laboratory, Cold Spring Harbor.
16. Chomczynski P., Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem. 162:1987;156-159.
17. Shimoda K., Begum N.A., Shibuta K., Mori M., Bonkovsky H.L., Banner B.F.et al. Interleukin-8 and hIRH (SDF1-α/PBSF) mRNA expression and histological activity index in patients with chronic hepatitis C. Hepatology. 28:1998;108-115.
18. Shi S.R., Key M.E., Klara K.L. Antigen retrieval in formalin-fixed paraffin-embedded tissues. An enhancement method for immuno-histochemical staining based on microwave oven heating of tissue sections. J. Histochem. Cytochem. 39:1991;741-748.
19. Cox D.R., Oakes D. Analysis of survival data. 1984;Chapmann Hall, New York.
20. Kaplan E.L., Meier P. Nonparametric estimation from incomplete observations. Am. Stat. Assoc. 53:1958;457.
21. Denekamp J. Vascular angiogenesis as a target for tumor therapy. Prog. Appl. Microcirc. 4:1984;28-38.
22. Ingber D., Fujita T., Kishimoto S., Sudo K., Kanamaru T., Brem H. Synthetic analogues of fumagillin that inhibit angiogenesis and suppress tumor growth. Nature. 348:1990;555-557.
23. Paley P.J., Staskus K.A., Gebhard K.et al. Vascular endothelial growth factor expression in early stage ovarian carcinoma. Cancer. 80:1997;98-105.
24. Cooper B.C., Ritchie J.M., Broghammer C.L.et al. Preoperative serum vascular endothelial growth factor levels: significance in ovarian cancer. J. Clin. Cancer Res. 8:2002;3192-3197.
25. Gawrychowski K., Skopi'nska-Rosewska E., Barcz E., Sommer E., Szaniawska B., Roskowska-Purska K. Angiogenic activity and interleukin-8 content of human ovarian cancer ascitis. Eur. J. Gynaecol. Oncol. XIX:1998;262-264.
26. Ivarsson K., Ekerydh A., Fyhr I., Janson P.O., Brannstrom M. Upregulation of interleukin-8 and polarized epithelial expression of interleukin-8 receptors A in ovarian carcinomas. Acta Obstet. Gynecol. Scand. 79:2000;777-784.
27. Dameron K.M., Volpert O.G., Tainsky M.A., Bouck N. Control of angiogenesis in fibroblasts by p53 regulation of thrompondin-1. Science. 265:1994;1582-1584.
28. Herrera C.A., Xu L., Bucana C.D.et al. Expression of metastasis-related genes in human epithelial ovarian cancer. Int. J. Oncol. 20:2002;5-13.
29. Sonoda T., Kobayashi H., Kaku T., Hirakawa T., Nakano H. Expression of angiogenesis factors in monolayer culture, multicellular spheroid and in vivo transplanted tumor by human ovarian cancer cell lines. Cancer Lett. 196:2003;227-229.
30. Piver M.S. Ovarian epithelial cancer. Piver M.S. Handbook of gynecologic oncology. vol. 17:1996;A Little, Brown and Company, Boston, MA, USA.
31. Hu Y.L., Tee M.K., Goetzl E.J.et al. Lypophosphatidic acid induction of vascular endothelial growth factor expression in human ovarian cancer cells. J. Natl. Cancer Inst. 93:2001;762-768.
32. Schwartz B.M., Hong G., Morrison B.H.et al. Lypophospholipids increase interleukin-8 expression in ovarian cancer cells. Gynecol. Oncol. 81:2001;291-300.